Package Leaflet: Information for the User
Toujeo 300 units/ml SoloStar solution for injection in a pre-filled pen
Insulin glargine
Each SoloStar pen delivers 1-80 units in steps of 1 unit.
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack and other information
Toujeo contains insulin, called “insulin glargine”. This is a modified insulin that is very similar to human insulin.
Toujeo contains three times more insulin in 1 ml than standard insulin that contains 100 units/ml.
It is used to treat diabetes mellitus in adults, adolescents, and children from 6 years of age. Diabetes mellitus is a disease where your body does not produce enough insulin to control your blood sugar levels.
Toujeo lowers your blood sugar levels over a long period of time. It is used once a day. If needed, you can change the time of your injection because this medicine lowers your blood sugar levels over a long period of time (for more information, see section 3).
Do not use Toujeo
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting Toujeo
Follow strictly the instructions on dosage, monitoring (blood and urine tests), diet, and physical activity (physical work and exercise) and injection technique established with your doctor.
You should pay special attention to the following:
Changes in the skin at the injection site
The injection site should be rotated to avoid changes in the skin, such as lumps under the skin. Insulin may not work well if injected into a lumpy area (see How to use Toujeo). Contact your doctor if you are currently injecting into a lumpy area, before starting to inject into a different area. Your doctor may advise you to check your blood sugar levels more closely and adjust your insulin or the dose of your other anti-diabetic medications.
Illnesses and injuries
The management of your diabetes may require extra care in the following situations (e.g. blood and urine tests):
In most cases, you will need to talk to a doctor. Contact your doctor as soon as you feel ill or have an injury.
If you have type 1 diabetes and are ill or have an injury:
Always inform the people in charge of your care or treatment that you have diabetes.
Treatment with insulin can cause your body to produce antibodies to insulin (substances that act against insulin). However, only in very rare cases will this require a change in your insulin dose.
Travel
Before travelling, consult your doctor. You may need to discuss:
Children and adolescents
This medicine should not be given to children under 6 years of age because there is no experience with Toujeo in this age group.
Using Toujeo with other medicines
Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medicines.
Some medicines may change your blood sugar level. This may mean that your insulin dose needs to be changed. Therefore, before taking any medicine, ask your doctor if it will affect your blood sugar level and what action to take if necessary. You also need to be careful when you stop taking a medicine.
Your blood sugar level may decrease (hypoglycaemia) if you take:
Your blood sugar level may increase (hyperglycaemia) if you take:
Your blood sugar level may increase or decrease if you take:
Beta-blockers
Beta-blockers, like other “sympatholytic medicines” (such as clonidine, guanethidine, reserpine - for high blood pressure), may make it more difficult to recognise the warning signs of low blood sugar (hypoglycaemia). They may even hide or interrupt the first signs of low blood sugar.
Pioglitazone used with insulin
Some patients with type 2 diabetes mellitus of long duration and previous heart disease or stroke who were treated with pioglitazone and insulin developed heart failure. Tell your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid weight gain or localised swelling (oedema). Tell your doctor as soon as possible.
If any of the above applies to you (or if you are not sure), tell your doctor, pharmacist, or nurse before using Toujeo.
Using Toujeo with alcohol
Your blood sugar level may increase or decrease if you drink alcohol. You should check your blood sugar level more often.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine. Your insulin dose may need to be changed during pregnancy and after delivery. It is very important for the health of your baby and for you to keep your diabetes under control and to prevent hypoglycaemia.
If you are breast-feeding, ask your doctor for advice. You may need to adjust your insulin dose and diet.
Driving and using machines
Low or high blood sugar levels or problems with your eyesight may affect your ability to drive and use machines. Your concentration may be affected. This can be dangerous for you and others.
Ask your doctor whether you can drive if:
Toujeo contains sodium
This medicine contains less than 1 mmol (23 mg) of sodium per dose, i.e. it is essentially “sodium-free”.
Follow exactly the instructions for administration of this medicine given by your doctor. If you are not sure, consult your doctor, pharmacist, or nurse again.
Although Toujeo contains the same active substance as insulin glargine 100 units/ml, these medicines are not interchangeable. Switching from one insulin treatment to another requires medical prescription, supervision, and monitoring of blood glucose. For more information, consult your doctor.
How much to use
The Toujeo SoloStar pre-filled pen can deliver doses of 1 to 80 units in one injection, in steps of 1 unit.
The dose window on the SoloStar pen shows the number of units of Toujeo to be injected. Do not adjust the dose.
Depending on your lifestyle, your blood sugar tests, and your previous insulin, your doctor will tell you:
Toujeo is a long-acting insulin. Your doctor may tell you to use it with a short-acting insulin or with other medicines for high blood sugar levels.
If you use more than one insulin, always check that you are using the correct insulin by checking the label on the insulin before each injection. Medication errors have been reported due to confusion between insulins, particularly between long-acting and rapid-acting insulins. The dose “300” is highlighted in gold on the label of your Toujeo SoloStar pre-filled pen. Consult your doctor and pharmacist if you have any doubts.
Many factors can influence your blood sugar level. You should know these factors so that you can react correctly to changes in your blood sugar level and prevent it from becoming too high or too low. For more information, see the box at the end of this leaflet.
Flexibility in administration time
Use in elderly patients (65 years and older)
If you are 65 years or older, tell your doctor, as you may need a lower dose.
If you have kidney or liver problems
If you have kidney or liver problems, tell your doctor, as you may need a lower dose.
Before injecting Toujeo
How to inject
To prevent the possible transmission of diseases, insulin pens should never be used by more than one person, even if the needle is changed.
Always insert a new sterile needle before each injection. Never re-use needles. If you re-use a needle, you increase the risk of blocked needles and getting too much or too little insulin.
Dispose of the used needle in a puncture-resistant container or as instructed by your pharmacist or local authorities.
Do not use Toujeo
Never use a syringe to withdraw Toujeo from your SoloStar pre-filled pen, as you may experience a severe overdose. See section 2.
If the SoloStar pen is damaged, it is because it has not been stored correctly. If you are not sure if it is working correctly or if your blood sugar control gets worse for no reason:
If you use more Toujeo than you should
If you have injected too much medicine, your blood sugar level may fall too low. Check your blood sugar level and eat more to prevent your blood sugar level from falling too low. If your blood sugar level falls too low, see the box at the end of this leaflet.
If you forget to use Toujeo
When needed, Toujeo can be injected up to 3 hours before or after your usual time.
If you have missed a dose of Toujeo or if you have not injected enough insulin, your blood sugar level may increase too much (hyperglycaemia):
If you stop using Toujeo
Do not stop your treatment without consulting your doctor. If you do, this could lead to very high blood sugar levels and an increase in acid in the blood (ketoacidosis).
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If you notice signs that your blood sugar level is too low (hypoglycemia),act immediately to raise your blood sugar level (see the box at the end of this leaflet).
Hypoglycemia (low blood sugar) can be very serious and is very common during insulin treatment (it can affect more than 1 in 10 people).
Low blood sugar means that there is not enough sugar in the blood.
If your blood sugar level drops too low, you may faint (lose consciousness).
A severe low blood sugar level can cause brain damage and can be potentially fatal. For more information, see the box at the end of this leaflet.
Severe allergic reactions(rare, may affect up to 1 in 1,000 people). The signs may include rash and itching all over the body, swelling of the skin or mouth, difficulty breathing, feeling of dizziness (drop in blood pressure) with rapid heartbeat and sweating. Severe allergic reactions can be potentially fatal. Inform your doctor immediately if you notice the signs of a severe allergic reaction.
Other Adverse Effects
Tell your doctor, pharmacist, or nurse if you notice any of the following adverse effects:
If insulin is injected too frequently in the same place, the fatty tissue can shrink (lipoatrophy, may affect up to 1 in 100 people) or become thicker (lipohypertrophy), (may affect up to 1 in 10 people). Lumps under the skin can also occur due to the accumulation of a protein called amyloid (cutaneous amyloidosis; the frequency of this is unknown). Insulin may not work very well if injected into a lumpy area. Change the injection site to help avoid these skin changes.
Frequent:may affect up to 1 in 10 people
Rare:may affect up to 1 in 1,000 people
Very Rare:may affect up to 1 in 10,000 people
Tell your doctor, pharmacist, or nurse if you notice any of the above adverse effects.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the carton and on the label of the pen after CAD. The expiration date is the last day of the month indicated.
Before First Use
Store in a refrigerator (between 2°C and 8°C).
Do not freeze or place near the freezer or a cold accumulator.
Keep the pen in the outer packaging to protect it from light.
After First Use or if Carried as a Reserve
Do not store the pen in the refrigerator. The pen can be stored for a maximum of 6 weeks below 30°C, protected from direct heat or direct light. Discard the pen after this period. Do not leave your insulin in a car on an exceptionally hot or cold day. When not in use, always put the pen cap on to protect it from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Toujeo
The other components are: zinc chloride, metacresol, glycerol, water for injectable preparations, sodium hydroxide (see section 2 "Toujeo contains sodium") and hydrochloric acid (for pH adjustment).
Appearance of Toujeo and Container Contents
Toujeo is a clear and colorless solution.
Each pen contains 1.5 ml of injectable solution (equivalent to 450 units).
Packaging of 1, 3, 5, and 10 pre-filled pens.
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Germany.
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Belgium Sanofi Belgium Tel: +32 (0)2 710 54 00 | Lithuania UAB sanofi-aventis Lietuva Tel: +370 5 2755224 |
Bulgaria SANOFI BULGARIA EOOD Tel: +359 (0)2 970 53 00 | Luxembourg Sanofi Belgium Tel: +32 (0)2 710 54 00 (Belgium) |
Czech Republic sanofi-aventis, s.r.o. Tel: +420 233 086 111 | Hungary sanofi-aventis zrt., Hungary Tel: +36 1 505 0050 |
Denmark Sanofi A/S Tel: +45 45 16 70 00 | Malta Sanofi S.p.A Tel: 39 02 39394275 |
Germany Sanofi-Aventis Deutschland GmbH Tel: 0800 52 52 010 Tel from abroad: +49 69 305 21 131 | Netherlands sanofi-aventis Netherlands B.V. Tel: +31 20 245 4000 |
Estonia sanofi-aventis Estonia OÜ Tel: +372 627 34 88 | Norway sanofi-aventis Norge AS Tel: +47 67 10 71 00 |
Greece sanofi-aventis AEBE Tel: +30 210 900 16 00 | Austria sanofi-aventis GmbH Tel: +43 1 80 185 – 0 |
Spain sanofi-aventis, S.A. Tel: +34 93 485 94 00 | Poland sanofi-aventis Sp. z o.o. Tel: +48 22 280 00 00 |
France sanofi-aventis France Tel: 0 800 222 555 Call from abroad: +33 1 57 63 23 23 | Portugal Sanofi - Produtos Farmacêuticos, Lda Tel: +351 21 35 89 400 |
Croatia sanofi-aventis Croatia d.o.o. Tel: +385 1 600 34 00 | Romania Sanofi Romania SRL Tel: +40 (0) 21 317 31 36 |
Ireland sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +353 (0) 1 403 56 00 | Slovenia sanofi-aventis d.o.o. Tel: +386 1 560 48 00 |
Iceland Vistor hf. Tel: +354 535 7000 | Slovakia sanofi-aventis Pharma Slovakia s.r.o. Tel: +421 2 33 100 100 |
Italy Sanofi S.p.A. Tel: 800 131212 (technical questions) 800 536389 (other questions) | Finland Sanofi Oy Tel: +358 (0) 201 200 300 |
Cyprus sanofi-aventis Cyprus Ltd. Tel: +357 22 871600 | Sweden Sanofi AB Tel: +46 (0)8 634 50 00 |
Latvia sanofi-aventis Latvia SIA Tel: +371 67 33 24 51 | United Kingdom Sanofi Tel: +44 (0) 845 372 7101 |
Date of Last Revision of this Leaflet:
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu.
HYPGLYCEMIA AND HYPERGLYCEMIA If you are taking insulin, you should always carry the following:
Hyperglycemia (high blood sugar levels) If your blood sugar level is too high (hyperglycemia), you may not have injected enough insulin. Reasons why hyperglycemia may occur Some examples are:
Warning signs of hyperglycemia Thirst, increased need to urinate, fatigue, dry skin, redness of the face, loss of appetite, low blood pressure, rapid heartbeat, and the presence of glucose and ketone bodies in the urine. Stomach pain, deep and rapid breathing, feeling sleepy or passing out (loss of consciousness) may be signs of a serious condition (ketoacidosis) caused by lack of insulin. What to do if you experience hyperglycemia?
Hypoglycemia (low blood sugar levels) If your blood sugar level drops too low, you may pass out (lose consciousness). Severe hypoglycemia can cause a heart attack or brain damage and can be life-threatening. You should learn to recognize the signs that indicate your blood sugar level is dropping, so you can take the necessary measures to prevent the situation from getting worse. Reasons why hypoglycemia may occur Some examples are:
It is also more likely to occur if:
Warning signs of hypoglycemia The first signs can be generally in your body. Examples of signs that your blood sugar level is dropping too low or too quickly are: sweating, moist and sticky skin, anxiety, rapid and irregular heartbeat, high blood pressure, and palpitations. These signs often occur before signs of low blood sugar in the brain appear. The signs in your brain include: headache, feeling very hungry, nausea, vomiting, feeling tired, drowsiness, agitation, sleep problems, aggressive behavior, difficulty concentrating, reduced reaction capacity, depression, feeling confused, difficulty speaking (sometimes, complete loss of speech), change in vision, tremors, inability to move (paralysis), tingling in hands or arms, feeling numb and tingling often around the mouth, feeling dizzy, loss of self-control, inability to take care of oneself, seizures, loss of consciousness. Situations in which the warning signs of hypoglycemia may be less clear: The first warning signs of hypoglycemia may change, weaken, or be absent if:
In these cases, you may experience severe hypoglycemia (and even pass out) before you realize what is happening. Always be familiar with your warning signs. If necessary, you may need to perform blood sugar tests more frequently. This can help identify mild hypoglycemic episodes. If you have difficulty recognizing your warning signs, you should avoid situations (such as driving a car) that could put you or others at risk due to hypoglycemia. What to do if you experience hypoglycemia?
Ask your doctor or nurse if you are not sure what to eat. With Toujeo, recovery from low blood sugar may be delayed because it has a prolonged action.
What should others do if you have hypoglycemia? Inform your family, friends, and people close to you that you need urgent medical help if you are unable to swallow or if you pass out (lose consciousness). You will need an injection of glucose or glucagon (a medication that increases blood sugar levels). These injections are justified even if you are not sure if you have hypoglycemia. It is recommended to check your blood sugar level immediately after ingesting glucose to confirm that you actually have hypoglycemia. |
Toujeo 300 units/ml solution for injection in pre-filled pen (SoloStar)
INSTRUCTIONS FOR USE
Read this first
Toujeo SoloStar contains 300 units/ml of insulin glarginein a 1.5 ml pre-filled disposable pen
Important information
Never share your pen - it is only for you.
Never use your pen if it is damaged or if you are not sure it is working correctly.
Always perform a safety test.
Always carry a spare pen and needles in case they are lost or stop working.
Learning to inject
Do you need help?
If you have questions about your pen or your diabetes, ask your doctor, pharmacist, or nurse or call the sanofi-aventis number listed at the beginning of this leaflet.
Additional items you will need:
Injection sites
Get to know your pen
STEP 1: Check your pen
Remove a new pen from the refrigerator at least 1 hour before your injection. Injecting cold insulin is more painful.
ACheck the name and expiration date on the label of your pen.
BRemove the pen cap.
CCheck that the insulin is clear.
STEP 2: Attach a new needle
Always use a new sterile needle for each injection. This will help prevent needle blockage, contamination, and infection.
Only use needles compatible with Toujeo (e.g., BD, Ypsomed Artsana, or Owen Mumford needles).
ATake a new needle and remove the protective seal.
BKeep the needle straight and screw it onto the pen until it is fixed. Do not overtighten.
CRemove the outer needle cap. Save it for later.
DRemove the inner needle cap and discard it.
Handling needles
STEP 3: Perform a safety test
Always perform a safety test before each injection to:
ASelect 3 units by turning the dose selector until the dose marker is between the 2 and 4 marks.
BPress the injection button all the way down.
If no insulin comes out:
If you see air bubbles
STEP 4: Select the dose
Never select the dose or press the injection button while the needle is not attached, as you may damage your pen.
AMake sure the needle is attached and the dose is set to "0".
BTurn the dose selector until the dose marker is aligned with your dose.
How to read the dose window
Even numbers are indicated on the same line as the dose marker:
30 units selected
Odd numbers are indicated as a line between the even numbers:
29 units selected
Insulin units in your pen
STEP 5: Inject the dose
If you have trouble pressing the injection button, do not force it, as you may break your pen. See the next section for help.
AChoose an injection site as shown in the drawing.
BPush the needle into your skin, just as your doctor, pharmacist, or nurse has taught you.
CPlace your thumb on the injection button. Press it all the way down and hold it down.
DHold the injection button down and when you see "0" in the dose window, count slowly to 5.
EAfter holding it down and counting slowly to 5, release the injection button. Then, remove the needle from your skin.
If you have trouble pressing the button:
STEP 6: Remove the needle
Be careful when handling needles to avoid puncture injuries and cross-infection.
Do not put the inner needle cap back on.
APut the outer needle cap on, and use it to unscrew the needle from the pen.
BDispose of the used needle in a puncture-resistant container, or as directed by your pharmacist or local authorities.
CPut the pen cap back on.
Use
How to store your pen
Before first use
After first use
How to care for your pen
Handle your pen with care
Protect your pen from dust and dirt
Disposing of your pen
The average price of Toujeo 300 unidades/ml solostar solucion inyectable en pluma precargada in October, 2025 is around 50.63 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.